Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated March 18, 2023, titled “Late-Breaking Phase 3 Data at AAD 2023 Show Oral Investigational Medicine Deuruxolitinib Significantly Improved……
| Subscribe To Our Free Newsletter |
